StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a report released on Tuesday. The firm set a “sell” rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Stock Down 0.2 %
NASDAQ AEZS opened at $5.86 on Tuesday. The stock’s 50-day simple moving average is $5.61 and its two-hundred day simple moving average is $7.13. Aeterna Zentaris has a twelve month low of $3.96 and a twelve month high of $12.00. The company has a market capitalization of $10.51 million, a price-to-earnings ratio of -0.39 and a beta of 1.55.
Aeterna Zentaris Company Profile
See Also
- Five stocks we like better than Aeterna Zentaris
- Profitably Trade Stocks at 52-Week Highs
- Target Hits the Mark: Q2 Earnings Exceed Expectations
- Manufacturing Stocks Investing
- Is Tesla’s Rebound Just Starting? Why You Should Consider Buying
- How to Read Stock Charts for Beginners
- Stanley Druckenmiller’s Latest Bet: MELI—Should You Follow Suit?
Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.